Transforaminal Versus Lateral Interbody Fusions for Treatment of Adjacent Segment Disease in the Lumbar Spine

被引:1
|
作者
Rajan, Prashant V. [1 ,2 ]
Megerian, Mark [3 ]
Desai, Ansh [3 ]
Halkiadakis, Penelope N. [3 ]
Rabah, Nicholas [2 ,3 ]
Shost, Michael D. [2 ,3 ]
Butt, Bilal [1 ,2 ]
Showery, James E. [2 ]
Grabel, Zachary [2 ]
Pelle, Dominic W. [1 ,2 ]
Savage, Jason W. [1 ,2 ]
机构
[1] Cleveland Clin Fdn, Neurol Inst, Ctr Spine Hlth, Dept Orthopaed Surg, Cleveland, OH USA
[2] Cleveland Clin Fdn, Neurol Inst, Ctr Spine Hlth, Dept Neurosurg, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
来源
CLINICAL SPINE SURGERY | 2025年 / 38卷 / 02期
关键词
PLIF; TLIF; LLIF; OLIF; ASD; spine outcomes; BLOOD-LOSS; DEGENERATION; SURGERY; RISK;
D O I
10.1097/BSD.0000000000001673
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design: Retrospective comparative study. Objective: This study compared outcomes for patients managed with a lateral approach to interbody fusion [lateral (LLIF) or oblique (OLIF)] versus a posterior (PLIF) or transforaminal interbody fusion (TLIF) for treatment of adjacent segment disease (ASD) above or below a prior lumbar fusion construct. Summary of Background Data: No study has compared outcomes of lateral approaches to more traditional posterior approaches for the treatment of ASD. Methods: Retrospective review was performed of patients who underwent single-level lateral or posterior approaches for lumbar interbody fusion for symptomatic ASD between January 2010 and December 2021. Exclusion criteria included skeletal immaturity (age below 18 y old) and surgery indication for malignancy or infection. Patient demographics, medical comorbidities, operative details, postoperative complications, and revision surgery profiles were collected for all patients. Standard descriptive statistics were used to summarize data. Comparative statistical analyses were performed using Statistical Package for the Social Sciences (Version 28.0.1.0; Chicago, IL). Results: A total of 152 patients (65 +/- 10 y) were included in the study with a mean duration of follow-up of 1.6 +/- 1.4 years. The cohort included 123 PLIF/TLIF (81%), 18 LLIF (12%), 11 OLIF (7%). TLIF/PLIF experienced greater mean operative time (210 +/- 62 min vs. 184 +/- 80 OLIF/105 +/- 64 LLIF, P<0.001) and estimated blood loss (414 +/- 254 mL vs. 49 +/- 29 OLIF/36 +/- 33 LLIF, P<0.001). No significant difference in rate of postoperative complications. Postoperative radicular pain was significantly greater in OLIF (7, 64%) and LLIF (7, 39%) compared with PLIF/TLIF (16, 13%), P<0.001. No statistically significant difference in health care utilization was noted between the groups. Conclusion: Lateral fusions to treat ASD demonstrated no significantly different risk of complication compared with posterior approaches. Our study demonstrated significantly increased operative time and estimated blood loss for the posterior approach and an increased risk of radicular pain from manipulation/retraction of psoas following lateral approaches.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 50 条
  • [1] Biomechanical evaluation of lumbar lateral interbody fusion for the treatment of adjacent segment disease
    Shasti, Mark
    Koenig, Scott J.
    Nash, Alysa B.
    Bahrami, Shahrzad
    Jauregui, Julio J.
    O'Hara, Nathan N.
    Jazini, Ehsan
    Gelb, Daniel E.
    Ludwig, Steven C.
    SPINE JOURNAL, 2019, 19 (03): : 545 - 551
  • [2] Single-Level Lateral Lumbar Interbody Fusion for the Treatment of Adjacent Segment Disease
    Aichmair, Alexander
    Alimi, Marjan
    Hughes, Alexander P.
    Sama, Andrew A.
    Du, Jerry Y.
    Hartl, Roger
    Burket, Jayme C.
    Lampe, Lukas P.
    Cammisa, Frank P.
    Girardi, Federico P.
    SPINE, 2017, 42 (09) : E515 - E522
  • [3] A Biomechanical Analysis of Lateral Interbody Construct and Supplemental Fixation in Adjacent-Segment Disease of the Lumbar Spine
    McMains, M. Craig
    Jain, Nikhil
    Malik, Azeem Tariq
    Cerier, Emily
    Litsky, Alan S.
    Yu, Elizabeth
    WORLD NEUROSURGERY, 2019, 128 : E694 - E699
  • [4] Sagittal Alignment as Predictor of Adjacent Segment Disease After Lumbar Transforaminal Interbody Fusion
    Sun, Jin
    Wang, Jun-Jie
    Zhang, Li-wei
    Huang, Hui
    Fu, Na-xin
    WORLD NEUROSURGERY, 2018, 110 : E567 - E571
  • [5] Biomechanical analysis of lateral interbody fusion strategies for adjacent segment degeneration in the lumbar spine
    Metzger, Melodie F.
    Robinson, Samuel T.
    Maldonado, Ruben C.
    Rawlinson, Jeremy
    Liu, John
    Acosta, Frank L.
    SPINE JOURNAL, 2017, 17 (07): : 1004 - 1011
  • [6] Lateral Lumbar Interbody Fusion and in Situ Screw Fixation for Rostral Adjacent Segment Stenosis of the Lumbar Spine
    Choi, Young Hoon
    Kwon, Shin Won
    Moon, Jung Hyeon
    Kim, Chi Heon
    Chung, Chun Kee
    Park, Sung Bae
    Heo, Won
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2017, 60 (06) : 755 - 762
  • [7] Posterior and Transforaminal Lumbar Interbody Fusion (PLIF/TLIF) for the Treatment of Localised Segment Degeneration of Lumbar Spine
    Kunze, B.
    Drasseck, T.
    Kluba, T.
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2011, 149 (03): : 312 - 316
  • [8] Comparison of adjacent segment disease after minimally invasive or open transforaminal lumbar interbody fusion
    Yee, Timothy J.
    Terman, Samuel W.
    La Marca, Frank
    Park, Paul
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (10) : 1796 - 1801
  • [9] A Comparative Study between Single-Level Oblique Lumbar Interbody Fusion with Transforaminal Lumbar Interbody Fusion for Lumbar Adjacent Segment Disease
    Chang, Chung-Tse
    Lin, Yu-Hsien
    Wu, Yun-Che
    Shih, Cheng-Min
    Chen, Kun-Hui
    Pan, Chien-Chou
    Lee, Cheng-Hung
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [10] Comparing Oblique Lumbar Interbody Fusion with Lateral Screw Fixation and Transforaminal Full-Endoscopic Lumbar Discectomy (OLIF-TELD) and Posterior Lumbar Interbody Fusion (PLIF) for the Treatment of Adjacent Segment Disease
    Yang, Zhuo
    Chang, Jianjun
    Sun, Lin
    Chen, Chien-Min
    Feng, Haoyu
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020